Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Managing chronic leukemias.

M N Silverstein

    Postgraduate Medicine
    |January 1, 1977
    PubMed
    Summary

    Chronic lymphocytic leukemia and chronic granulocytic leukemia have poor prognoses despite chemotherapy. Research is exploring immunotherapy as a promising adjunctive treatment for granulocytic leukemia.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A clinical update in polycythemia vera and essential thrombocythemia.

    The American journal of medicine·2000
    Same author

    Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients.

    Blood·2000
    Same author

    Treatment of polycythaemia vera and essential thrombocythaemia.

    Bailliere's clinical haematology·2000
    Same author

    Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County Study, 1976-1995.

    American journal of hematology·1999
    Same author

    Treatment of essential thrombocythemia with anagrelide.

    Seminars in hematology·1999
    Same author

    Splenic irradiation for symptomatic splenomegaly associated with myelofibrosis with myeloid metaplasia.

    British journal of haematology·1998

    Area of Science:

    • Hematology
    • Oncology

    Background:

    • Chronic lymphocytic leukemia (CLL) and chronic granulocytic leukemia (CGL) present distinct clinical and laboratory characteristics.
    • Both leukemia types typically exhibit a poor prognosis.

    Purpose of the Study:

    • To outline the varying features and treatment approaches for CLL and CGL.
    • To highlight the current therapeutic mainstays and emerging treatment modalities.

    Main Methods:

    • Review of clinical features, laboratory findings, and therapeutic strategies for CLL and CGL.
    • Discussion of supportive care measures for complications like anemia and splenomegaly.

    Main Results:

    • Chemotherapy is the primary treatment for both CLL and CGL.
    • Supportive therapies are crucial for managing complications.
    • Immunotherapy shows potential for CGL treatment.

    Conclusions:

    • Despite varied presentations, CLL and CGL share a generally unfavorable prognosis.
    • Current treatment relies heavily on chemotherapy and supportive care.
    • Immunotherapy represents a promising future direction for CGL management.

    Related Experiment Videos